Jundishapur Journal of Natural Pharmaceutical Products
The Official Journal of Ahvaz Jundishapur University of Medical Sciences
TREATMENT OF OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS: SODIUM FLUORIDE OR CALCITONIN
Abstract
Copyright
© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Efficacy of Oral Alendronate Versus Zoledronic Acid on Postmenopausal Osteoporosis
Najafi S, Rezasoltani Z, Azma K, Nayeb Abbas S, Aghaei M, et al. Efficacy of Oral Alendronate Versus Zoledronic Acid on Postmenopausal Osteoporosis. Ann Mil Health Sci Res. 2019;17(2):e86960. doi: https://doi.org/10.5812/amh.86960
The Effect of Systemic Delivery of Bisphosphonates on Trabecular and Cortical Bone Mass of Ovariectomized Rats
Shahrezaee MH, Shahrezaee M, Oryan A, Kamali SA, Sajadi S, et al. The Effect of Systemic Delivery of Bisphosphonates on Trabecular and Cortical Bone Mass of Ovariectomized Rats. Ann Mil Health Sci Res. 2018;16(4):e86830. doi: https://doi.org/10.5812/amh.86830
Bone Mineral Density in Iranian Female patients with Rheumatoid Arthritis
Zakeri Z. Bone Mineral Density in Iranian Female patients with Rheumatoid Arthritis. Shiraz E-Med J. 2010;11(3):20391. doi:
Comparison of Osteoporosis Pharmacotherapy Fracture Rates: Analysis of a MarketScan® Claims Database Cohort
Reynolds AW, Liu G, Kocis PT, Skowronski JN, Leslie DL, et al. Comparison of Osteoporosis Pharmacotherapy Fracture Rates: Analysis of a MarketScan® Claims Database Cohort. Int J Endocrinol Metab. 2018;16(3):e12104. doi: https://doi.org/10.5812/ijem.12104
Evaluation of Bone Density Changes Before and After One Year of Denosumab (Prolia) Administration in Osteoporosis Patients
G. Soroosh M, Kazemi A, Ahkiani M. Evaluation of Bone Density Changes Before and After One Year of Denosumab (Prolia) Administration in Osteoporosis Patients. Ann Mil Health Sci Res. 2024;22(1):e143361. doi: https://doi.org/10.5812/amh-143361
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 0
Last Update: 2 weeks ago
- Scopus by Title (Ref): 0
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 6 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC